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A 62-year-old man with a recent diagnosis of primary central
nervous system lymphoma developed acute kidney injury
(AKI) after administration of high-dose methotrexate. AKI
developed within 48 h of therapy despite prior infusion of
intravenous bicarbonate solution. Serum methotrexate level
was 2.61 mmol/l at 24 h and 0.25 mmol/l 72 h after metho-
trexate administration. Urinalysis was negative for hematuria,
proteinuria, or pyuria. Urine microscopy revealed amor-
phous brown precipitates (Figure 1). To determine whether
these findings were consistent with methotrexate precipita-
tion, we added sodium methotrexate solution to a buffered
acidic solution (pH 4.7). The resulting precipitates (Figure 2)
were similar in color and morphology to those observed in
the patient’s urine. Urine methotrexate level was 4.9 mmol/l as
measured by fluorescence polarization immunoassay. Meth-
otrexate-induced AKI is attributed to tubular obstruction due
to precipitation of methotrexate, which may be exacerbated
by low urinary pH and reduced tubular flow due to
hypovolemia. To our knowledge, this is the first case of
urinary methotrexate precipitates in the medical literature.
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Figure 1 |Methotrexate precipitation in the urine. Figure 2 | Sodium methotrexate in buffered acidic solution.
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